INVA

Innoviva, Inc.

15.64 USD
-0.03 (-0.19%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Innoviva, Inc. stock is down -6.18% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 56.25% of the previous 15 February’s closed higher than January.

About Innoviva, Inc.

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma.